{"References": [{"title": "Phosphodiesterase 5 inhibitors: a novel therapy for heart failure", "authors": "Kukreja, R.C., Salloum, F.N., Das, A.", "journal": "Trends in Cardiovascular Medicine", "year": "2011", "volumes": "21", "first page": "37", "last page": "44", "DOI": "10.1016/j.tcm.2012.03.001"}, {"title": "Phosphodiesterase-5 inhibition in pulmonary hypertension", "authors": "Ghofrani, H.A., Osterloh, I.H., Grimminger, F.", "journal": "The Lancet", "year": "2006", "volumes": "367", "first page": "1551", "last page": "1559", "DOI": "10.1016/S0140-6736(06)68653-8"}, {"title": "Phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction and beyond", "authors": "Francis, S.H., Blount, M.A., Corbin, J.D.", "journal": "Nature Reviews Drug Discovery", "year": "2011", "volumes": "10", "first page": "757", "last page": "768", "DOI": "10.1038/nrd3503"}, {"title": "Phosphodiesterase-5 inhibition improves insulin resistance and inflammation in a mouse model of diet-induced obesity", "authors": "Ayala, J.E., Bracy, D.P., Julien, B.M., Rottman, J.N., Fueger, P.T., Wasserman, D.H.", "journal": "Diabetes", "year": "2007", "volumes": "56", "first page": "2191", "last page": "2200", "DOI": "10.2337/db07-0248"}, {"title": "Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia", "authors": "McVary, K.T.", "journal": "Current Opinion in Urology", "year": "2011", "volumes": "21", "first page": "11", "last page": "19", "DOI": "10.1097/MOU.0b013e32834100a1"}, {"title": "Phosphodiesterase-5 inhibition and the heart: molecular mechanisms and clinical implications", "authors": "Das, A., Durrant, D., Salloum, F.N., Xi, L., Kukreja, R.C.", "journal": "Recent Patents on Cardiovascular Drug Discovery", "year": "2009", "volumes": "4", "first page": "230", "last page": "238", "DOI": "10.2174/157489009789004802"}, {"title": "Phosphodiesterase type 5 inhibitors and cancer: current knowledge and future perspectives", "authors": "Das, A., Durrant, D., Salloum, F.N., Xi, L., Kukreja, R.C.", "journal": "Urologic Oncology: Seminars and Original Investigations", "year": "2015", "volumes": "33", "first page": "145", "last page": "151", "DOI": "10.1016/j.urolonc.2014.11.012"}, {"title": "Phosphodiesterase-5 inhibitors and the aging male", "authors": "Corona, G., Rastrelli, G., Maseroli, E., Forti, G., Maggi, M.", "journal": "World Journal of Men's Health", "year": "2013", "volumes": "31", "first page": "12", "last page": "25", "DOI": "10.5534/wjmh.2013.31.1.12"}, {"title": "Phosphodiesterase type 5 inhibitors and endothelial function: a novel mechanism for cardiovascular protection", "authors": "Kukreja, R.C., Salloum, F.N., Das, A.", "journal": "Trends in Cardiovascular Medicine", "year": "2012", "volumes": "22", "first page": "289", "last page": "294", "DOI": "10.1016/j.tcm.2012.08.001"}, {"title": "Phosphodiesterase-5 inhibitors in the treatment of non-urological diseases", "authors": "Kloner, R.A., Brown, M., Prisant, L.M., Collins, M., Materson, B.J., Kaplan, N.M., Messerli, F.H.", "journal": "Current Hypertension Reports", "year": "2011", "volumes": "13", "first page": "478", "last page": "484", "DOI": "10.1007/s11906-011-0223-0"}]}